#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	728	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1320	29.3	0	.	p	.	0	K29T	NONSYN	85	87	AAG	432	434	ACG	30;32;33	A;C;G	30;32;33	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	L121Q	0	.	.	361	363	CTG	359	361	CTG	133;132;130	C;T;G	132;131;129	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	Q125K	0	.	.	373	375	CAG	371	373	CAG	122;119;118	C;A;G	120;118;116	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	Q125R	0	.	.	373	375	CAG	371	373	CAG	122;119;118	C;A;G	120;118;116	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	Q125E	0	.	.	373	375	CAG	371	373	CAG	122;119;118	C;A;G	120;118;116	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	Y161C	0	.	.	481	483	TAC	479	481	TAC	126;126;125	T;A;C	126;126;124	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	Y161D	0	.	.	481	483	TAC	479	481	TAC	126;126;125	T;A;C	126;126;124	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	Y161N	0	.	.	481	483	TAC	479	481	TAC	126;126;125	T;A;C	126;126;124	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	G317D	0	.	.	949	951	GGC	947	949	GGC	115;116;117	G,A;G;C	114,1;114;117	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1124	1126	GCA	82;80;78	G;C;A	78;76;77	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1124	1126	GCA	82;80;78	G;C;A	78;76;77	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1133	1135	GAA	78;79;79	G;A;A	78;79;77	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	0	HET	.	.	.	C954T	.	954	954	C	952	952	C	113	C,T	63,50	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	0	HET	.	.	.	T135C	.	135	135	T	133	133	T	69	T,C	35,22	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	179	2640	Escherichia_coli_EF_Tu	1185	1183	99.83	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1334	94.1	0	HET	.	.	.	C210T	.	210	210	C	208	208	C	96	C,T	44,52	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1094	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1913	30.1	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1644	1646	AAA	20;19;18	A;A;A	20;19;18	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1334	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1864	37.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1341	1343	GAA	46;46;44	G;A;A	46;46;44	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	302	H_NS	414	414	99.03	H_NS.l15.c17.ctg.1	904	17.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	175	G	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	171	C,T	170,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	158	C	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	150	T	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	179	C,G	175,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	130	C	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	135	A	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	144	A	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	148	A	148	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	142	T	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	144	C	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	127	C	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	124	A	123	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	116	G	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	114	C	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	127	T	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	173	G	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	174	G	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	174	T	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	193	T	192	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	190	G	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	148	C,T	146,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	133	A	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	82	C	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	76	C	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	32	A	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	32	A	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	31	G	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	35	C	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	98	T	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	105	G	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	61	T	61	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	543	158.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	183	C	183	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	112	93.75	Pasteurella_multocida_16S.l15.c17.ctg.5	165	43.1	0	.	n	.	0	T50C	SNP	50	50	T	102	102	C	57	C	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	112	93.75	Pasteurella_multocida_16S.l15.c17.ctg.5	165	43.1	0	.	n	.	0	G74A	SNP	74	74	G	126	126	A	14	A	14	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	112	93.75	Pasteurella_multocida_16S.l15.c17.ctg.5	165	43.1	0	.	n	.	0	G81.	DEL	81	81	G	132	132	A	12	A	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	112	93.75	Pasteurella_multocida_16S.l15.c17.ctg.5	165	43.1	0	.	n	.	0	A83C	SNP	83	83	A	134	134	C	12	C	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	112	93.75	Pasteurella_multocida_16S.l15.c17.ctg.5	165	43.1	0	.	n	.	0	T92G	SNP	92	92	T	143	143	G	13	G	13	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	112	93.75	Pasteurella_multocida_16S.l15.c17.ctg.5	165	43.1	0	.	n	.	0	C94.	DEL	94	94	C	144	144	T	12	T,C	10,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	112	93.75	Pasteurella_multocida_16S.l15.c17.ctg.5	165	43.1	0	.	n	.	0	T97C	SNP	97	97	T	147	147	C	12	C	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	13	G	13	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	16	A	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	A1003C	SNP	1003	1003	A	53	53	C	16	C	16	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	G1008C	SNP	1008	1008	G	58	58	C	19	C	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	20	T	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	T1012C	SNP	1012	1012	T	62	62	C	20	C	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	C1023A	SNP	1023	1023	C	72	72	A	38	A	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	.1025G	INS	1025	1025	T	75	75	G	38	G	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	42	G	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	3656	Pasteurella_multocida_16S	1551	142	90.21	Pasteurella_multocida_16S.l15.c17.ctg.6	142	19.0	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	41	T	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1056	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1663	33.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	272	274	CGT	22;23;22	C;G;T	22;23;21	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1056	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1663	33.6	0	.	p	.	0	V30I	NONSYN	88	90	GTC	356	358	ATC	41;42;42	A;T;C	41;42;42	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1056	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1663	33.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1115	1117	GGC	37;37;36	G;G;C	37;37;36	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1610	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2099	40.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	240	242	AGC	23;23;23	A;G;C	23;23;23	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1610	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2099	40.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	642	644	CTA	40;40;40	C;T,A;A	39;39,1;40	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1610	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2099	40.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1161	1163	CAA	57;63;64	C;A,G;A	57;62,1;64	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1610	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2099	40.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1260	1262	GGT	50;49;48	G;G;T	50;49;48	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1610	PmrC	1644	1644	99.15	PmrC.l15.c30.ctg.1	2099	40.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1830	1832	GTT	29;29;26	G;T;T	29;28;26	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1634	19.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	617	619	GAA	29;28;28	G;A;A	29;28;28	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1634	19.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	797	799	ACC	13;13;14	A;C;C	12;13;13	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1634	19.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	917	919	ACT	13;10;10	A;C;T	13;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1634	19.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1307	1309	ATC	12;12;14	A;T;C	11;12;13	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	860	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1418	32.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	40	TEM_1+	858	155	98.71	TEM_1+.l6.c30.ctg.1	155	2.1	0	.	p	.	0	V82I	NONSYN	244	246	GTT	125	127	ATT	2;2;1	A;T;T	2;2;1	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	40	TEM_1+	858	152	100.0	TEM_1+.l6.c30.ctg.2	152	2.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	512	40	TEM_1+	858	106	98.11	TEM_1+.l6.c30.ctg.3	167	1.9	0	.	p	.	0	K4Q	NONSYN	10	12	AAA	71	73	CAA	3;3;3	C;A;A	3;3;3	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2612	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3635	38.0	0	.	p	.	0	T85I	NONSYN	253	255	ACC	553	555	ATC	39;38;38	A;T;C	39;38;38	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2612	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3635	38.0	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2266	2268	AAG	48;49;48	A;A;G	47;49;48	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1004	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1649	32.3	0	.	p	.	0	A22V	NONSYN	64	66	GCC	248	250	GTC	9;9;8	G;T;C	9;9;8	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1004	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1649	32.3	0	.	p	.	0	S269C	NONSYN	805	807	AGC	989	991	TGC	63;63;65	T;G;C	63;62;65	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2506	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3120	42.2	0	.	p	.	0	S46trunc	TRUNC	136	136	T	451	451	T	20	T	20	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2506	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3120	42.2	0	.	p	.	0	G148D	NONSYN	442	444	GGC	757	759	GAC	39;38;37	G;A;C	39;38;37	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2506	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3120	42.2	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1033	1035	TTA	29;30;30	T;T;A	29;30;30	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2506	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3120	42.2	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1216	1218	AAT	34;34;34	A;A;T	34;33;34	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2506	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3120	42.2	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2003	2003	T	56	T	56	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	566	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1113	26.5	1	SNP	p	R45C	0	.	.	133	135	CGC	374	376	CGC	42;42;41	C;G;C	42;42;41	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	534	acrS	663	663	98.64	acrS.l15.c17.ctg.1	1199	23.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	374	376	TTC	25;24;25	T;T;C	25;24;25	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	534	acrS	663	663	98.64	acrS.l15.c17.ctg.1	1199	23.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	638	640	GGG	33;31;34	G;G;G	33;31;34	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	732	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1364	28.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	695	697	CTT	47;48;50	C;T;T	47;48;49	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2852	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3316	45.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2152	2154	GCA	56;60;63	G,A;C;A	55,1;60;63	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2852	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3316	45.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2413	2415	ACC	76;76;75	A;C;C	75;76;75	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2852	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3316	45.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2722	2724	GCC	40;40;38	G;C;C	40;39;38	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1278	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2587	26.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	417	419	GCT	7;10;13	G;C;T	7;10;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1278	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2587	26.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	537	539	GAG	6;6;6	G;A;G	5;5;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1278	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2587	26.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	573	575	TGC	10;10;11	T;G;C	10;10;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1278	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2587	26.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	756	758	GTT	22;23;23	G;T;T	21;23;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1278	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2587	26.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	906	908	CAC	21;20;18	C;A;C	21;20;18	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1278	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2587	26.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1191	1193	ATG	48;48;48	A;T;G	48;48;48	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1278	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2587	26.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2187	2189	CGC	22;23;23	C;G;C	22;23;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	586	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1267	24.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	850	852	ACC	21;19;20	A;C;C	21;19;20	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	586	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1267	24.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	862	864	TCG	21;22;22	T;C;G	20;22;22	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	504	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1202	22.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	922	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1639	29.0	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1354	1356	AAA	11;12;12	A;A;A	10;12;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	922	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1639	29.0	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1366	1368	GAG	15;14;14	G;A;G	15;13;14	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	922	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1639	29.0	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1372	1374	CAC	15;15;15	C;A;C	15;15;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	922	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1639	29.0	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1426	1428	GAG	20;22;22	G;A;G	20;22;22	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1256	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1863	35.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	830	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1308	33.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	730	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1485	25.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	691	693	ACT	36;37;37	A;C;T	36;37;37	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	430	dfrA1_1	474	474	100.0	dfrA1_1.l15.c17.ctg.1	819	26.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
dfrA15.3003013.KF534911.39_513.2102	dfrA15.3003013.KF534911.39_513.2102	1	0	16	32	dfrA15	474	99	96.97	dfrA15.l6.c4.ctg.3	102	3.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA15;dfrA15 is an integron-encoded dihydrofolate reductase found in Vibrio cholerae
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	978	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1670	31.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	943	945	GTC	48;48;49	G;T;C	48;48;49	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1562	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2202	37.6	0	.	p	.	0	E197K	NONSYN	589	591	GAA	920	922	AAA	56;56;54	A;A;A	56;56;54	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1012	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1782	29.8	0	.	p	.	0	G209S	NONSYN	625	627	GGC	888	890	AGC	34;34;30	A;G;C	34;34;30	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	42	emrE_1	333	94	96.81	emrE_1.l15.c4.ctg.2	94	10.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	714	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1603	23.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	786	788	AGG	26;26;27	A;G,T;G	25;25,1;26	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	714	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1603	23.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1176	1178	GAC	13;12;11	G;A;C	13;12;11	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	572	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1103	27.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1112	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2111	27.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	476	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1230	20.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	480	482	CTG	24;25;26	C;T;G	24;25;26	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	459	461	ATA	12;12;10	A;T;A	12;12;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	471	473	GTA	9;9;9	G;T;A	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	624	626	ACG	22;22;19	A;C;G	21;22;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	687	689	GAA	40;40;40	G;A;A	40;40;40	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	726	728	GCT	39;38;38	G;C;T	39;38;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	744	746	GAT	28;27;27	G;A;T	28;27;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	831	833	TCA	28;24;23	T;C;A	28;24;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	960	962	CAG	16;15;16	C;A;G	16;15;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1098	1100	GTT	15;14;14	G;T;T	15;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1254	1256	GAT	5;6;6	G;A;T	5;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1422	1424	AAT	9;9;9	A;A;T	9;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1443	1445	TTA	2;2;2	T;T;A	2;2;2	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1644	1646	AAA	14;13;13	A;A;A	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2379	2381	CAT	30;30;31	C;A;T,C	30;30;30,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2433	2435	CAT	16;15;14	C;A;T	16;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2451	2453	AGA	19;19;18	A;G;A	19;19;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2466	2468	AAT	19;20;21	A;A;T	19;20;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2613	2615	TCC	13;15;14	T;C;C	13;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2778	2780	ATT	26;26;27	A;T;T	26;26;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2799	2801	GAT	26;27;28	G;A;T	26;27;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2913	2915	GTT	26;27;25	G;T;T	26;27;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2040	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4218	25.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3198	3200	CAC	38;36;37	C;A;C	37;36;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1475	28.5	1	SNP	p	P64S	0	.	.	190	192	CCA	512	514	CCA	59;58;58	C;C;A	59;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1475	28.5	1	SNP	p	P64A	0	.	.	190	192	CCA	512	514	CCA	59;58;58	C;C;A	59;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1475	28.5	1	SNP	p	P64R	0	.	.	190	192	CCA	512	514	CCA	59;58;58	C;C;A	59;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1475	28.5	1	SNP	p	P64L	0	.	.	190	192	CCA	512	514	CCA	59;58;58	C;C;A	59;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	794	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1475	28.5	1	SNP	p	P64H	0	.	.	190	192	CCA	512	514	CCA	59;58;58	C;C;A	59;58;58	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	504	gadE	528	528	100.0	gadE.l6.c4.ctg.1	1175	22.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	229	96.07	gadW.l6.c30.ctg.1	250	14.4	0	.	p	.	0	S234A	NONSYN	700	702	TCG	200	202	GCG	10;10;10	G;C;G	9;10;10	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l6.c30.ctg.2	320	7.6	0	.	p	.	0	E54D	NONSYN	160	162	GAA	3	5	GAT	2;4;4	G;A;T	2;3;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l6.c30.ctg.2	320	7.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	105	107	ATG	3;3;3	A;T;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l6.c30.ctg.2	320	7.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	108	110	CCG	3;3;3	C;C;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l6.c30.ctg.2	320	7.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	141	143	GAA	3;3;3	G;A;A	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l6.c30.ctg.2	320	7.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	144	146	TCC	3;3;3	T;C;C	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l6.c30.ctg.2	320	7.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	147	149	GGG	3;3;3	G;G;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	130	gadW	729	319	93.1	gadW.l6.c30.ctg.2	320	7.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	171	173	AAT	6;6;6	A;A;T	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	568	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1284	23.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	427	429	TTA	25;25;25	T;T;A	25;25;25	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	568	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1284	23.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	505	507	ATT	20;20;19	A;T;T	20;20;19	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	568	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1284	23.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1006	1008	GGA	32;31;31	G;G;A,T	31;31;30,1	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	568	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1284	23.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1012	1014	CCG	32;31;30	C;C;G	32;30;30	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2353	2355	GAA	54;54;57	G;A;A	54;53;57	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	S83W	0	.	.	247	249	TCG	568	570	TCG	53;53;53	T;C;G	52;53;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	S83I	0	.	.	247	249	TCG	568	570	TCG	53;53;53	T;C;G	52;53;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	S83L	0	.	.	247	249	TCG	568	570	TCG	53;53;53	T;C;G	52;53;53	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	D87H	0	.	.	259	261	GAC	580	582	GAC	44;44;44	G;A;C	43;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	D87G	0	.	.	259	261	GAC	580	582	GAC	44;44;44	G;A;C	43;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	D87N	0	.	.	259	261	GAC	580	582	GAC	44;44;44	G;A;C	43;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	D87V	0	.	.	259	261	GAC	580	582	GAC	44;44;44	G;A;C	43;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2686	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3236	44.2	1	SNP	p	D87Y	0	.	.	259	261	GAC	580	582	GAC	44;44;44	G;A;C	43;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2094	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3013	37.0	1	SNP	p	R136H	0	.	.	406	408	CGC	726	728	CGC	52;50;48	C;G;C	51;50;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2094	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3013	37.0	1	SNP	p	R136E	0	.	.	406	408	CGC	726	728	CGC	52;50;48	C;G;C	51;50;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2094	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3013	37.0	1	SNP	p	R136L	0	.	.	406	408	CGC	726	728	CGC	52;50;48	C;G;C	51;50;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2094	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3013	37.0	1	SNP	p	R136G	0	.	.	406	408	CGC	726	728	CGC	52;50;48	C;G;C	51;50;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2094	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3013	37.0	1	SNP	p	R136S	0	.	.	406	408	CGC	726	728	CGC	52;50;48	C;G;C	51;50;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2094	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3013	37.0	1	SNP	p	R136C	0	.	.	406	408	CGC	726	728	CGC	52;50;48	C;G;C	51;50;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2094	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3013	37.0	1	SNP	p	R136I	0	.	.	406	408	CGC	726	728	CGC	52;50;48	C;G;C	51;50;48	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	488	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1143	22.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	471	473	CCG	24;23;23	C;C;G	23;23;23	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	488	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1143	22.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	624	626	GCC	26;27;28	G;C;C	25;27;27	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	944	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1456	34.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	302	304	TCA	25;25;26	T;C;A	25;25;26	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	292	marA	384	384	99.74	marA.l15.c4.ctg.1	946	16.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	613	615	AGC	6;6;6	A;G;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	715	717	CAT	8;8;8	C;A;T	7;6;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	V45E	0	.	.	133	135	GTG	439	441	GTG	24;24;24	G,T;T;G	23,1;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	I49S	0	.	.	145	147	ATC	451	453	ATC	20;20;20	A;T;C	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	A70T	0	.	.	208	210	GCA	514	516	GCA	19;19;19	G;C;A	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	R73S	0	.	.	217	219	CGT	523	525	CGT	18;18;18	C;G;T	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	R73C	0	.	.	217	219	CGT	523	525	CGT	18;18;18	C;G;T	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	R77C	0	.	.	229	231	CGC	535	537	CGC	17;15;15	C;G;C	17;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	R77L	0	.	.	229	231	CGC	535	537	CGC	17;15;15	C;G;C	17;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	L78M	0	.	.	232	234	CTG	538	540	CTG	15;15;14	C;T;G	15;15;14	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	R94S	0	.	.	280	282	CGC	586	588	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	R94H	0	.	.	280	282	CGC	586	588	CGC	5;5;5	C;G;C	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	160	marR	435	435	97.7	marR.l15.c4.ctg.1	768	10.7	1	SNP	p	V96E	0	.	.	286	288	GTA	592	594	GTA	5;5;5	G;T;A	5;5;5	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	S7F	NONSYN	19	21	TCC	49	51	TTC	4;4;4	T;T;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	R36I	NONSYN	106	108	AGG	136	138	ATC	16;16;13	A;T;C	16;16;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	E42A	NONSYN	124	126	GAA	154	156	GCC	8;8;8	G;C;C	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	N43V	NONSYN	127	129	AAT	157	159	GTG	10;10;12	G;T;G	10;10;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	E52D	NONSYN	154	156	GAG	184	186	GAT	18;18;17	G;A;T	18;18;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	N59T	NONSYN	175	177	AAC	205	207	ACC	18;18;18	A;C;C	18;18;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	I68L	NONSYN	202	204	ATA	232	234	TTA	17;16;16	T;T;A	17;16;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	373	375	CAG	44;43;43	C;A;G	43;43;43	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	D128A	NONSYN	382	384	GAC	412	414	GCC	26;26;26	G;C;C	25;26;26	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	S163A	NONSYN	487	489	TCG	517	519	GCG	36;37;41	G;C;G	36;37;41	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	L231V	NONSYN	691	693	CTT	721	723	GTT	27;28;27	G;T;T	20;26;24	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	659	832	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1358	31.2	0	.	p	.	0	R285fs	FSHIFT	853	853	C	883	883	C	29	C	29	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	740	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1787	21.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	235	235	G	25	G	25	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	740	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1787	21.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	292	294	CAG	18;18;20	C;A;G	18;18;20	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	740	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1787	21.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	442	444	ATC	26;24;25	A;T;C	26;24;24	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	740	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1787	21.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	490	492	ATG	11;12;12	A;T;G	11;12;12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	740	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1787	21.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	583	585	ACC	23;24;28	A;C;C	23;24;28	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	740	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1787	21.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	964	966	ACG	36;36;35	A;C;G	36;36;35	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2742	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3555	40.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1956	1958	ACC	53;51;49	A;C;C	53;50;49	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2742	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3555	40.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2349	2351	CAA	41;41;39	C;A;A	40;40;37	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2742	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3555	40.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2517	2519	ATT	30;28;27	A;T,A;T	30;27,1;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2742	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3555	40.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2601	2603	GTT	39;39;38	G;T;T	39;38;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2742	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3555	40.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2709	2711	GAG	29;27;26	G;A;G	29;26;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2742	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3555	40.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2937	2939	ATG	32;32;30	A;T;G	32;31;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2742	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3555	40.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3072	3074	GAT	36;37;39	G;A;T	35;35;37	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2400	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3309	38.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	332	334	ATG	16;16;17	A;T;G	15;16;17	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2400	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3309	38.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	818	820	ATC	39;39;39	A;T;C	38;39;39	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2400	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3309	38.0	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3134	3136	CAC	10;9;9	C;A;C	10;8;9	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2400	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3309	38.0	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3137	3139	CTC	9;9;9	C;T;C	8;9;9	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1090	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2030	28.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	309	311	GAA	18;18;19	G;A;A	18;18;19	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1090	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2030	28.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	978	980	GCG	35;35;35	G;C;G	35;35;35	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1090	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2030	28.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1320	1322	ATC	35;34;34	A;T;C	34;34;33	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1090	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2030	28.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1623	1625	TTT	48;49;50	T;T;T	48;49;50	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1100	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1717	33.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2902	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3675	42.0	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1154	1156	ACC	40;40;39	A;C,A;C	40;29,1;38	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2902	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3675	42.0	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2396	2398	GAC	53;51;51	G;A;C	52;50;50	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1060	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1588	28.6	0	.	p	.	0	V200I	NONSYN	598	600	GTC	709	711	ATC	26;27;30	A;T;C	26;26;30	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1060	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	573	15.5	0	.	p	.	0	E5G	NONSYN	13	15	GAA	185	187	GGA	9;10;10	G;G;A	9;10;10	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	904	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1676	28.6	0	.	p	.	0	G134C	NONSYN	400	402	GGT	652	654	TGT	54;53;53	T,G;G;T	53,1;53;52	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	904	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1676	28.6	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1222	1224	TTG	26;27;25	T;T;G	25;27;25	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	904	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1676	28.6	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1432	1434	ACG	10;10;10	A;C;G	10;10;10	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1142	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1845	32.7	0	.	p	.	0	A185S	NONSYN	553	555	GCC	875	877	TCC	35;34;35	T;C;C	33;34;35	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	754	mdtN	1032	1032	98.02	mdtN.l6.c4.ctg.1	1604	24.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	602	604	ATT	27;26;26	A;T;T	27;26;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	224	226	ATG	16;17;17	A;T;G	16;17;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	290	292	ATC	26;25;27	A;T;C	25;25;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	539	541	CGC	51;50;49	C;G;C	51;50;48	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	905	907	AGC	34;34;34	A;G,C;C	34;31,1;33	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1106	1108	GTG	38;38;40	G;T;G	38;30;39	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1169	1171	AAC	16;16;17	A;A;C	12;12;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1214	1216	GTC	24;24;24	G;T;C	23;23;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1244	1246	ATA	26;26;24	A;T;A	26;26;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1352	1354	TCT	35;36;36	T;C;T	35;36;36	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1739	1741	GCG	43;42;41	G;C;G,C	43;41;40,1	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1702	mdtO	2052	2052	98.1	mdtO.l15.c17.ctg.1	2607	34.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1952	1954	ATC	46;47;49	A;T;C	46;47;49	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	637	639	GCG	37;35;35	G;C,G;G	36;33,1;35	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	811	813	ACC	35;35;36	A;C;C	34;35;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	883	885	CGC	39;40;41	C;G;C	39;40;41	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1000	1002	GCT	34;32;32	G;C;T	32;31;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1084	1086	AAA	23;23;24	A;A;A	22;22;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1102	1104	CGA	26;26;25	C;G;A	26;26;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1267	1269	GCC	23;23;24	G;C;C	23;22;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1279	1281	GAT	17;17;17	G;A;T	17;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1008	mdtP	1467	1467	97.96	mdtP.l6.c4.ctg.1	1940	27.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1696	1698	GCT	17;15;15	G;C;T	17;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2968	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4054	38.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1554	1556	AAG	33;33;33	A;A;G	32;32;31	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2968	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4054	38.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2631	2633	CTG	39;39;39	C;T;G	39;39;39	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	176	mgrB	144	144	100.0	mgrB.l15.c17.ctg.1	360	20.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1772	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2274	41.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1066	1068	AAC	36;36;40	A;A;C	35;35;39	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1772	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2274	41.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1612	1614	ATA	42;41;39	A;T;A	42;41;39	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1226	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1720	37.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1361	1363	GAT	53;53;52	G;A;T	52;53;52	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1226	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1720	37.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1364	1366	CTG	53;54;53	C;T;G	53;54;53	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	885	20.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	281	283	TGT	20;19;20	T;G;T	20;19;20	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	885	20.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	551	553	ACC	25;25;23	A;C;C	24;24;22	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	885	20.0	1	SNP	p	R15C	0	.	.	43	45	CGC	245	247	CGC	29;29;28	C;G;C	29;29;28	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	379	98.94	nfsA.l6.c30.ctg.1	885	20.0	1	SNP	p	S33R	0	.	.	97	99	AGC	299	301	AGC	23;22;21	A;G;C	23;22;21	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	353	98.87	nfsA.l6.c30.ctg.2	912	17.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	398	400	GAC	29;29;29	G;A;C	29;29;29	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	353	98.87	nfsA.l6.c30.ctg.2	912	17.0	0	.	p	.	0	W237G	NONSYN	709	711	TGG	548	550	GGG	24;24;25	G,T;G;G	1,19;23;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	353	98.87	nfsA.l6.c30.ctg.2	912	17.0	1	SNP	p	G131D	0	.	.	391	393	GGC	230	232	GGC	22;22;22	G;G;C	22;22;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	353	98.87	nfsA.l6.c30.ctg.2	912	17.0	1	SNP	p	R203L	0	.	.	607	609	CGT	446	448	CGT	42;40;40	C;G;T	42;40;40	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	636	nfsA	723	353	98.87	nfsA.l6.c30.ctg.2	912	17.0	1	SNP	p	R203C	0	.	.	607	609	CGT	446	448	CGT	42;40;40	C;G;T	42;40;40	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1222	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1397	44.7	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1020	1022	GAG	65;63;64	G;A;G	65;62;64	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1222	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1397	44.7	1	SNP	p	G141E	0	.	.	421	423	GGT	507	509	GGT	51;52;54	G;G;T	51;52;54	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1222	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1397	44.7	1	SNP	p	G141D	0	.	.	421	423	GGT	507	509	GGT	51;52;54	G;G;T	51;52;54	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1222	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1397	44.7	1	SNP	p	R154D	0	.	.	460	462	CGT	546	548	CGT	63;62;64	C;G;T	63;62;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1222	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1397	44.7	1	SNP	p	R154A	0	.	.	460	462	CGT	546	548	CGT	63;62;64	C;G;T	63;62;64	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2324	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2795	44.2	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1854	1856	GTG	51;50;51	G;T;G	51;50;51	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2324	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2795	44.2	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1881	1883	TCG	53;54;56	T;C;G	51;53;55	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2324	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2795	44.2	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2496	2498	AAC	32;31;31	A;A;C	31;31;31	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2324	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2795	44.2	1	SNP	p	A85T	0	.	.	253	255	GCG	510	512	GCG	59;59;60	G;C;G	56;58;57	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2324	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2795	44.2	1	SNP	p	D111H	0	.	.	331	333	GAT	588	590	GAT	40;42;43	G;A;T	40;42;43	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2324	parC_2	2259	2259	99.2	parC_2.l6.c30.ctg.1	2795	44.2	1	SNP	p	S129P	0	.	.	385	387	TCC	642	644	TCC	38;36;35	T;C;C	37;36;35	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1362	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2408	29.9	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1622	1624	AAC	37;37;39	A;A;C	37;37;39	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1362	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2408	29.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1631	1633	GAT	34;33;32	G;A;T	34;33;32	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1414	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2110	35.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	938	940	CAG	42;41;42	C;A;G	42;41;41	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1414	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2110	35.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1412	1414	GAT	45;44;46	G;A;T	44;44;46	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	V146F	0	.	.	436	438	GTT	713	715	GTT	63;61;61	G;T;T	62;60;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1814	1816	CAG	38;36;35	C;A;G	38;36;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1814	1816	CAG	38;36;35	C;A;G	38;36;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1853	1855	CAC	56;57;55	C;A;C	55;57;54	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1862	1864	CGT	58;56;56	C;G;T	58;56;54	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1862	1864	CGT	58;56;56	C;G;T	58;56;54	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1868	1870	TCC	58;57;57	T;C;C	58;57;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1874	1876	CTC	53;54;53	C;T;C	52;54;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1964	1966	ACC	41;41;42	A;C;C	41;40;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1967	1969	CCT	45;43;42	C;C;T	43;43;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4326	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4645	49.4	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2336	2338	CGT	75;74;71	C;G;T	75;74;70	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	.	n	.	0	A226G	SNP	226	226	A	294	294	G	358	G	356	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	1	SNP	n	A794T	0	.	.	794	794	A	862	862	A	327	A	318	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	1	SNP	n	A794G	0	.	.	794	794	A	862	862	A	327	A	318	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	1	SNP	n	G926C	0	.	.	926	926	G	994	994	G	305	G,A	304,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	1	SNP	n	G926A	0	.	.	926	926	G	994	994	G	305	G,A	304,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	1	SNP	n	G926T	0	.	.	926	926	G	994	994	G	305	G,A	304,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	A253T	.	253	253	A	321	321	A	320	A,T	253,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	G474A	.	474	474	G	542	542	G	325	G,A	252,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	C194T	.	194	194	C	262	262	C	303	C,T	237,63	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	A79G	.	79	79	A	147	147	A	309	A,G	229,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	C719T	.	719	719	C	787	787	C	284	C,T	150,132	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	T273A	.	273	273	T	341	341	T	325	T,A	249,66	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	T90C	.	90	90	T	158	158	T	293	T,C	218,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	C183T	.	183	183	C	251	251	C	282	C,T	186,94	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.1	1069	307.0	0	HET	.	.	.	A250T	.	250	250	A	318	318	A	319	A,T	250,65	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	340.4	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	229	A	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	340.4	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	229	A	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	340.4	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	229	A	225	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	58.5	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	105	A	105	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	58.5	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	110	C	110	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	58.5	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	110	C	109	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	58.5	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	120	G	117	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	58.5	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	116	G	116	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	142	95.1	rrsB+.l15.c30.ctg.3	142	58.5	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	101	T	101	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	10824	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.4	143	66.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	662	sat_1	525	525	100.0	sat_1.l6.c30.ctg.1	1227	28.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	456	soxR	465	465	100.0	soxR.l15.c30.ctg.1	959	25.0	1	SNP	p	R20H	0	.	.	58	60	CGC	350	352	CGC	36;40;41	C;G;C	36;40;41	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	456	soxR	465	465	100.0	soxR.l15.c30.ctg.1	959	25.0	1	SNP	p	G121D	0	.	.	361	363	GGT	653	655	GGT	38;38;38	G;G;T	38;38;38	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	268	soxS_1	324	324	99.69	soxS_1.l6.c4.ctg.1	865	16.5	1	SNP	p	A12S	0	.	.	34	36	GCA	321	323	GCA	30;31;31	G;C;A	30;31;31	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	539	6862	APH_3____Ib+	804	804	99.88	APH_3____Ib+.l15.c30.ctg.1	1405	258.9	0	.	p	.	0	P121Q	NONSYN	361	363	CCG	656	658	CAG	437;434;441	C;A;G	429;431;438	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	7314	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1415	273.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	4984	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1504	175.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul2;Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	7232	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1911	200.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	4572	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1223	197.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1418	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2150	35.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
